search results for 
Logo

Disclosures on directors’ dealings and shareholdings in 2013

Members of the Management and Supervisory Boards of the general partner, members of the Supervisory Board of Fresenius SE & Co. KGaA, other executive officers, and persons closely related to them are required, pursuant to Section 15a of the German Securities Trading Act (WpHG), to disclose purchases and sales of Fresenius SE & Co. KGaA’s shares and financial instruments based on them (directors’ dealings). Directors’ dealings in 2013 are disclosed in the table below.

directors’ Dealings Management Board


2013 Name Quantity Price in €1  Total volume in € Type of transaction
December 2 Dr. U. M. Schneider 23,860 63.00 1,503,151.56 Stock option exercise2
November 28 S. Sturm 19,660 60.68 1,192,901.40 Stock option exercise2
November 26 Dr. J. Götz 28,380 49.52 1,405,388.55 Stock option exercise2
November 26 Dr. E. Wastler 36,300 66.70 2,421,156.50 Stock option exercise2
November 25 Dr. U. M. Schneider 25,800 48.29 1,245,856.25 Stock option exercise2
November 8 S. Sturm 10,000 66.59 665,940.82 Stock option exercise2
November 7 S. Sturm 40,000 57.84 2,313,648.72 Stock option exercise2
November 7 Dr. E. Wastler 32,400 47.13 1,526,988.42 Stock option exercise2
November 6 Dr. J. Götz 58,920 50.90 2,999,028.36 Stock option exercise2
August 2 M. Henriksson 13,800 63.10 870,812.88 Stock option exercise2
May 27 Dr. F. De Meo 68,122 50.46 3,437,545.23 Stock option exercise2

2013 Name Quantity Price in €1  Total volume in € Type of transaction
December 2 Dr. U. M. Schneider 23,860 63.00 1,503,151.56 Stock option exercise2
November 28 S. Sturm 19,660 60.68 1,192,901.40 Stock option exercise2
November 26 Dr. J. Götz 28,380 49.52 1,405,388.55 Stock option exercise2
November 26 Dr. E. Wastler 36,300 66.70 2,421,156.50 Stock option exercise2
November 25 Dr. U. M. Schneider 25,800 48.29 1,245,856.25 Stock option exercise2
November 8 S. Sturm 10,000 66.59 665,940.82 Stock option exercise2
November 7 S. Sturm 40,000 57.84 2,313,648.72 Stock option exercise2
November 7 Dr. E. Wastler 32,400 47.13 1,526,988.42 Stock option exercise2
November 6 Dr. J. Götz 58,920 50.90 2,999,028.36 Stock option exercise2
August 2 M. Henriksson 13,800 63.10 870,812.88 Stock option exercise2
May 27 Dr. F. De Meo 68,122 50.46 3,437,545.23 Stock option exercise2

Pursuant to number 6.3 of the Code, ownership of shares of the Company and financial instruments based on them must be disclosed by Management Board and Supervisory Board members if more than 1% of the shares issued by the Company are held either directly or indirectly. None of the Management or Supervisory Board members of the general partner or of the Supervisory Board of Fresenius SE & Co. KGaA directly or indirectly holds more than 1% of the shares issued by Fresenius or any related financial instruments.

The members of the Management and Supervisory Boards of Fresenius Management SE and the members of the Supervisory Board of Fresenius SE & Co. KGaA together hold 0.95% of the shares of Fresenius SE & Co. KGaA outstanding as of December 31, 2013, in the form of shares or related financial instruments and stock options under the Fresenius SE & Co. KGaA stock option plans. 0.46% are held by members of the Management Board of Fresenius Management SE, 0.49% by members of the Supervisory Board of Fresenius Management SE, and 0.48% by members of the Supervisory Board of Fresenius SE & Co. KGaA. Due to the fact that some persons are members of both Supervisory Boards, the amount of shares or related financial instruments and stock options held by the Boards of Fresenius SE & Co. KGaA and Fresenius Management SE in total is smaller than the cumulative holdings of the three Boards as reported herein.

There were no notifications that the shareholdings of members of the Management and Supervisory Boards had reached, exceeded, or fallen below the reporting thresholds stipulated in the German Securities Trading Act.

Continue reading:
Transparency and Communication

QUICKFINDER

History

External related links

Tools